Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
A substantial number of breast cancer patients are identified as being at high risk of developing metastatic disease. With increasing number of targeted therapeutics entering clinical trials, chronic administration of these agents may be a feasible approach for the prevention of metastases within this subgroup of patients. |